1703. Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in <i>Streptococcus mitis-oralis In Vitro</i> and in an <i>Ex Vivo</i> Simulated Endocarditis Model
Open forum infectious diseases